STALLERGENES: 2007: A Further Year of Strong Grow... ( PARIS January 15 /- (EURO Mil...)

HOME >> BIOLOGY >> TECHNOLOGY

STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%

Date:1/15/2008

PARIS, January 15 /PRNewswire-FirstCall/ --

(EURO Millions) 2007 2006 07/06

% % %

Sales Sales Change

Southern Europe(1) 31.99 74.3 27.97 74.7 14

Other EU Countries (2) 9.66 22.4 8.22 22.0 17

Other Markets 1.40 3.3 1.27 3.3 10

SLIT 34.55 80.3 28.75 76.8 20

SCIT 7.12 16.5 6.86 18.3 4

Other Products 1.38 3.2 1.85 4.9 (25)

Total Q4 Sales 43.05 100.0 37.46 100.0 15

Southern Europe (1) 109.15 74.2 93.68 74.0 17

Other EU Countries (2) 32.49 22.1 28.00 22.1 16

Other Markets 5.42 3.7 4.87 3.9 11

FY Sales 147.06 100.0 126.55 100.0 16

SLIT 116.43 79.2 96.30 76.1 21

SCIT 24.90 16.9 24.09 19.0 3

Other Products 5.73 3.9 6.16 4.9 (7)

FY Cumulated Sales 147.06 100.0 126.55 100.0 16

(1) Portugal, Spain, France, Italy, Greece; (2) including Switzerland

Sales growth and financial position

2007 4th quarter sales registered a further 15% growth in all markets. 2007 full-year growth was 16%, driven by the strength of the sublingual route desensitisation segment (SLIT), which grew 21%. The significant increase in the number of new patients, in particular in France and Germany, and growing sales excluding subsidiaries were the main growth drivers.

2007 results, should exceed those of 2006 (EBIT of EUR 23 million), in spite of
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
2. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
3. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
4. SAFC Hitech(TM) Plans Further Expansion Into Asia
5. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
6. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
7. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
10. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
11. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products

Post Your Comments:

(Date:2/8/2010)... 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... financial results for the second quarter of fiscal ... "After rigorous evaluation of numerous global in-licensing opportunities, ... Melbourne -based drug development company, into YM ... , Chairman & CEO of YM BioSciences Inc. ...

(Date:2/8/2010)... , Feb. 8 Biocell ... with maternal-fetal-medicine doctors by attending the Society for ... has been working with perinatologists and Ob/Gyn doctors ... , CEO of Biocell Center Corporation. "We understand ... mothers and families and we are hoping to ...

(Date:2/8/2010)... to present the critical processes that comprise a more accurate ... ... Chicago, IL (PRWEB) February 8, 2010 ... software, today announced that both Kristin Lucas and Kelly Larrabee, ... at the CBI Forecasting & Budgeting conference at the Marriott ...

(Date:2/8/2010)... announce that it has hired Lisa Wichman and Sahar Meyer to its ... an Account Manager and will focus on key healthcare markets in the ... that group Omaha, NE. , ... Foothill Ranch, CA (Vocus) February 8, ... the hiring of a new Account Manager and Manager of Analytics. , ...

[0] YM BioSciences reports second quarter 2010 operational and financial results [0] Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine [0] ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference [0] Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions

... and MTAX: CTIC) management to hold a conference call ... update on Zevalin asset,purchase, CMS reimbursement, and PIX301 timing ... December 27 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 ... at http://www.cticseattle.com - webcast will ...

... RICHMOND, Va., Dec. 26 Insmed Inc. (Nasdaq:,INSM), ... that it has requested a hearing before a ... Determination to delist the,Company,s common stock from the ... from the Nasdaq Stock Market ("Nasdaq") on,December 20, ...

... CEO -, DALLAS, Dec. 26 Access Pharmaceuticals, ... Jeffrey B.,Davis has been appointed to the additional role ... CEO of the Company for health reasons. Mr.,Seiler has ... believe that Access has an exciting future with ProLindac(TM),MuGard(TM), ...

Other Biology Technology:Insmed to Appeal Delisting Notification From Nasdaq 2 Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 2 Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 3

Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline Insmed to Appeal Delisting Notification From Nasdaq Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO

(Date:2/8/2010)... to a significantly elevated risk of having a child ... an exhaustive study of all births in California during ... paternal age is associated with elevated autism risk only ... under 30, the study found. , Published online today ... Research, the study, "Independent and Dependent Contributions of ...

(Date:2/7/2010)... (NCI) have found that the prevalence of tamoxifen use ... a personal history of breast cancer is very low. ... breast cancer in women who are at increased risk ... published in the February issue of Cancer Epidemiology, ... Association for Cancer Research. , The low prevalence ...

(Date:2/7/2010)... Consuming two or more soft drinks per week increased ... compared to individuals who did not consume soft drinks, ... & Prevention , a journal of the American Association ... cancer remains one of the most deadly, and only ... five years later. , Mark Pereira, Ph.D., senior author ...

Breaking Biology News(10 mins):UC Davis study confirms link between advanced maternal age and autism 2 UC Davis study confirms link between advanced maternal age and autism 3 UC Davis study confirms link between advanced maternal age and autism 4 Few women take tamoxifen to prevent breast cancer 2 Soft drink consumption may increase risk of pancreatic cancer 2 Perfect Fathers Day Gift 3A The Sound of Silence 47810 1 Perfect Fathers Day Gift 3A The Sound of Silence 47810 2 Perfect Fathers Day Gift 3A The Sound of Silence 47810 3 Two Drugs Better Than One for Crohns Patients 47809 1 Two Drugs Better Than One for Crohns Patients 47809 2 Two Drugs Better Than One for Crohns Patients 47809 3 Pay for Performance Doesnt Shortchange Patients 47807 1 Pay for Performance Doesnt Shortchange Patients 47807 2 Pay for Performance Doesnt Shortchange Patients 47807 3

[0] UC Davis study confirms link between advanced maternal age and autism [0] Few women take tamoxifen to prevent breast cancer [0] Soft drink consumption may increase risk of pancreatic cancer

... research has shown that reduced calorie intake can increase ... and his collaborators* have discovered that reducing calorie intake ... health and longevity benefits of life-long calorie reduction. Importantly, ... using this knowledge to establish a novel screening technique ...

... according to scientific gospel, social behavior is dictated primarily ... reproduction. , That may well be true for many ... the University of Wisconsin-Madison have found evidence that social ... be with one another. What's more, the researchers say, ...

... a unique protein from jellyfish that could be inserted ... cause them to radiate a brilliant green color. This ... many new discoveries regarding how living cells function. But ... detection: plants harbor tough cell walls and enormous ...

Other Biology News:It's never too late to get it back! Aging interrupted 2 In young mice, gregariousness seems to reside in the genes 2 In young mice, gregariousness seems to reside in the genes 3

It's never too late to get it back! Aging interrupted In young mice, gregariousness seems to reside in the genes Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants

Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...

Biotin d anti-mouse Tim-1...

... protein. The epitope is specific for ... any other known protein.,SPECIES REACTIVITIES: ... rabbit, bovine, porcine and guinea pig. ... and mouse (17/19 residues) and chick ...

Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...

Biology Products:

Rabbit Anti-Human Kallikrein 1 Polyclonal Antibody, Unconjugated from Abcam Rat Anti-Mouse Tim-1 Monoclonal Antibody, Biotin Conjugated, Clone RMT1-4 from BioLegend Anti-Potassium Channel, Inward Rectifier Kir2.1 Polyclonal Antibody, Unconjugated from CHEMICON Mouse Anti-Thyroid Hormone Receptor beta 1 Monoclonal Antibody, Unconjugated, Clone J53 from Abcam

STALLERGENES: 2007: A Further Year of Strong Grow...( PARIS January 15 /- (EURO Mil...)